← back to search

Ian Ganly

Pediatrics and Genetics · US
Area of research
Surgery · Otorhinolaryngology
Research interest
Research interests include Head and Neck Cancer Studies, Thyroid Cancer Diagnosis and Treatment, Salivary Gland Tumors Diagnosis and Treatment, and Head and Neck Surgical Oncology.
h-index
89
citations
31,983
works
764
NIH funding
primary concept
Medicine
email

Recent publications

Comparable Outcomes of Differentiated Thyroid Cancer in Immunocompromised Versus Immunocompetent Patients.
2026cited by 0position: contributordoi
Approach to the patient: Oncocytic thyroid cancer.
2026cited by 0position: contributordoi
Genomic Enrichment and Functional Impact of TP53 and CYLD Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer.
2026cited by 0position: contributordoi
Osteoradionecrosis as a complication following post-operative intensity-modulated radiation therapy or proton therapy for oral cavity cancer
Oral Oncology 2025cited by 8position: contributordoi
Impact of gross extrathyroidal extension to the recurrent laryngeal nerve alone on survival in papillary thyroid carcinoma.
2025cited by 2position: contributordoi
Hypoxia-Directed Treatment of Human Papillomavirus-Related Oropharyngeal Carcinoma.
2024cited by 70position: contributordoi
Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma
JAMA Otolaryngology–Head & Neck Surgery 2024cited by 28position: middledoi
Skull base surgery for malignant tumors: The 2nd international collaborative study (1995–2015)
Head & Neck 2024cited by 8position: middledoi
Outcomes of SMARCB1-deficient sinonasal carcinoma: Largest single-center cross-sectional study.
2024cited by 5position: contributordoi
A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for In Vivo Assessment in Oral Cancer.
2024cited by 5position: contributordoi
Skull base surgery for malignant tumors: The 2nd international collaborative study (1995-2015).
2024cited by 4position: contributordoi
Parotidectomy for deep lobe pleomorphic adenomas is associated with higher rates of complications and recurrence.
2024cited by 2position: contributordoi
Analysis of growth rate and safety of observation for pleomorphic adenomas in pregnancy: A retrospective case series.
2024cited by 1position: contributordoi
Supplementary Figure S5 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi
Supplementary Figure S6 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi
Supplementary Figure S3 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi
Supplementary Figure S10 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi
Supplementary Figure S2 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi
Supplementary Video S1 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi
Supplementary Figure S1 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi
Supplementary Figure S2 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi
Supplementary Video S1 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi
Supplementary Video S3 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi
Supplementary Video S5 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi
Supplementary Figure S7 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi
Supplementary Table S2 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi
Supplementary Table S3 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi
Supplementary Figure S9 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi
Supplementary Figure S11 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi
Supplementary Video S5 from A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for <i>In Vivo</i> Assessment in Oral Cancer
2024cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 147 papers (2019–2026)Ronald A Ghossein · New York University126 papers (2020–2024)Timothy A. Chan · Cleveland Clinic83 papers (2013–2023)Bin Xu · Heilongjiang Bayi Agricultural University82 papers (2019–2023)Luc G.T. Morris · Weill Cornell Medicine81 papers (2021–2023) · 80 papers (2022–2023)Yiyu Dong · Guangxi Medical University80 papers (2022–2023) · 80 papers (2022–2023) · 80 papers (2022–2023)Daniel Scholfield · Memorial Sloan Kettering Cancer Center48 papers (2023–2024)Dauren Adilbay · Memorial Sloan Kettering Cancer Center48 papers (2020–2024)Cristina Valero · Sechenov University48 papers (2020–2024)Daniella Karassawa Zanoni · Italian Oncology Group of Clinical Research46 papers (2020–2024)Snehal G. Patel · Pediatrics and Genetics46 papers (2020–2024)Paula Demétrio De Souza França · University of Wisconsin–Madison46 papers (2020–2024)Gary Peterson · Memorial Sloan Kettering Cancer Center45 papers (2024–2024)Stephen W. Dusza · Memorial Sloan Kettering Cancer Center45 papers (2024–2024)Pablo H. Montero · Pontificia Universidad Católica de Chile45 papers (2024–2024)Naga Vara Kishore Pillarsetty · Kettering University45 papers (2024–2024)Marco Ardigo · Humanitas University45 papers (2024–2024)